Advertisement
Screener

Karyopharm Therapeutics Inc. (KPTI) Debt Securities, Available-for-sale, Noncurrent

2.2 / 5 stars · 36/82 Roast Me

Karyopharm Therapeutics Inc. Debt Securities, Available-for-sale, Noncurrent

Karyopharm Therapeutics Inc. (KPTI) had Debt Securities, Available-for-sale, Noncurrent of $2.00 million as of 2021-09-30, per its 10-Q filed 2021-11-03.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments

us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2022-03-01

  • 2021-09-30: Debt Securities, Available-for-sale, Noncurrent $2.00M.
  • 2021-06-30: Debt Securities, Available-for-sale, Noncurrent $2.01M.
  • 2021-03-31: Debt Securities, Available-for-sale, Noncurrent $7.68M.
  • 2020-12-31: Debt Securities, Available-for-sale, Noncurrent $24.21M.
Period endDebt Securities, Available-for-sale, Noncurrent
2021-09-30$2.00M
10-Q · filed 2021-11-03
2021-06-30$2.01M
10-Q · filed 2021-08-05
2021-03-31$7.68M
10-Q · filed 2021-05-04
2020-12-31$24.21M
10-K · filed 2022-03-01
2020-09-30$39.37M
10-Q · filed 2020-11-02
2020-06-30$48.86M
10-Q · filed 2020-08-04
2020-03-31$31.37M
10-Q · filed 2020-05-05
2019-12-31$2.02M
10-K · filed 2021-02-24
2019-09-30$2.02M
10-Q · filed 2019-11-04
2018-12-31$2.00M
10-K · filed 2020-02-26
2018-09-30$4.80M
10-Q · filed 2018-11-08
2018-06-30$8.78M
10-Q · filed 2018-08-07
2017-12-31$29.40M
10-K · filed 2019-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Kairos Pharma, LTD. (KAPA)United States$0.041B
PMGC Holdings Inc. (ELAB)United States$0.037B
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45